1. Bardon S., Vignon, F., Chalbos, D., and Rochefort H., 1985, RU 486, a progestin and glucocorticoid antagonist inhibits the growth of breast cancer cells via the progesterone receptor, J. Clin. Endocr. Metab. in press.
2. Baulieu, E. E., 1983, The progesterone receptor, in “Progestogens in Therapy,” G. Benagiano, P. Zulli and E. Diczfaluzy, eds., Raven Press, New York, pp 27–38.
3. Baulieu, E. E. and Raynaud, J. P., 1970, A “proportion graph” method for measuring binding systems, Eur. J. Biochem. 13:293–304.
4. Baulieu, E. E.. and Ulmann, A., 1985, RU 486: April 1985 update, this volume.
5. Bergstrom, S., Diczfalusy, E., Borell, U., Karim, S., Samuelsson, B., Uvnas, B., Wiqvist, N., and Bygdeman, M., 1972, Prostaglandins in fertility control, Science 175:1280–1287.